Forschung
Lehre
Lösungen
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Atherothrombosis and Vascular Biology
Karlheinz Peter has not added Biography.
If you are Karlheinz Peter and would like to personalize this page please email our Author Liaison for assistance.
Mesoscale Nanoparticles: An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases!
Hypertension (Dallas, Tex. : 1979) 01, 2018 | Pubmed ID: 29133359
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.
Nature communications 02, 2018 | Pubmed ID: 29410422
Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.
Molecular therapy : the journal of the American Society of Gene Therapy 04, 2018 | Pubmed ID: 29525742
Baker Heart & Diabetes Institute
Monash University
Tatjana Michel1,
Antonia Link1,
Meike-Kristin Abraham1,2,
Christian Schlensak1,
Karlheinz Peter2,3,
Hans-Peter Wendel1,
Xiaowei Wang2,3,
Stefanie Krajewski1
1Department of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University Medical Center,
2Atherothrombosis and Vascular Biology, Baker Heart & Diabetes Institute,
3Department of Medicine, Monash University
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten
